Ads
related to: novartis stock price
Search results
SageView Advisory Group LLC Acquires 718 Shares of Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 2 days agoSageView Advisory Group LLC boosted its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 30.6% in the fourth quarter, according to the company in its most recent ...
Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday
Zacks via Yahoo Finance· 6 days agoNovartis NVS was closing in on buying the company. However, no such deals materialized as Novartis...
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 22 hours agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 15 hours agoWhat began Tuesday as a puzzling dip in shares of the biotech Moderna accelerated into a larger...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 7 days agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...
A corner of the cancer therapy market is heating up—Here are the names investors need to know
CNBC· 7 days agoThere's been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by binding a radioactive particle to a targeted ...
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Zacks via Yahoo Finance· 7 days agoNovartis NVS for €68 per share or an aggregate of €2.7 billion. The acquisition will add late-stage...
Investors say 'no bueno' as Cytokinetics stymies M&A prospects with complex Royalty deal
FierceBiotech· 7 days agoThe complicated strategic funding deal drew the ire of investors, who sent the stock down 14% in...
Calliditas Therapeutics’ stock surges after $1.1 billion takeover bid
Market Watch· 2 days agoThe Asahi Kasei cash offer of 208 Swedish kronor per share represents an 83% premium to the closing ...
Asahi Kasei to Buy Swedish Biotech for Rare Disease Drug
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Japanese industrial group Asahi Kasei Corp. plans to buy Swedish biotechnology firm...